Area of research
Surgery · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Cancer, Lipids, and Metabolism, and Blood Pressure and Hypertension Studies.
Targeting <i>APOC3</i> with Olezarsen in Moderate Hypertriglyceridemia
Glucagon-like peptide-1 receptor agonists and muscle mass effects
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk
Endothelial MICU1 protects against vascular inflammation and atherosclerosis by inhibiting mitochondrial calcium uptake
Expert opinion on the integration of combination therapy into the treatment algorithm for the management of dyslipidaemia: the integration of ezetimibe and bempedoic acid may enhance goal attainment
Upfront lipid-lowering combination therapy in high cardiovascular risk patients: a route to effective atherosclerotic cardiovascular disease prevention
The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021
2024: The Year in Cardiovascular Disease - The Year of Lipoprotein(a) – Research Advances and New Findings.
Global, regional, and national burden of Chagas disease, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
Enhancing human gut health: Global innovations in dysbiosis management
Non-Traditional Cardiovascular Risk Factors: Tailored Assessment and Clinical Implications
Global Trends in Ischemic Heart Disease-Related Mortality From 2000 to 2019
Inclisiran-based treatment strategy in hypercholesterolaemia: the VICTORION-difference trial
Academia Europaea’s guidelines for the visualization of clinical outcomes
Global, regional, and national burden of neck pain, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
Global, regional, and national burden of gout, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
Digital health and mobile health: a bibliometric analysis of the 100 most cited papers and their contributing authors
The quality of care and long-term mortality of out of hospital cardiac arrest survivors after acute myocardial infarction: a nationwide cohort study
Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis
The promise of digital healthcare technologies
The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories
Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)
Eliminating atherosclerotic cardiovascular disease residual risk
Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement
Bempedoic acid lowers high-sensitivity C-reactive protein and low-density lipoprotein cholesterol: Analysis of pooled data from four phase 3 clinical trials
Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity: an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004–2015 studies
Knowledge of Primary Care Patients Living in the Urban Areas about Risk Factors of Arterial Hypertension
Prevalence of statin intolerance: a meta-analysis